Fig. 4From: Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 studyRatios T subpopulations/Treg. Ratio Tmemory/Treg (mean values)Back to article page